New prodrug for treating chronic hepatitis B shows promise in real world study. Similar to tenofovir alafenamide (recommended in 2017, still waiting to be listed on the PBS). When will this one be available? https://x.com/xiahepublishing/status/1886942908076441765
@xiahepublishing.bsky.social
@xiahepublishing.bsky.social
Comments